retatrutide study results π¨ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A in those with concurrent obesity and type 2 diabetes. π Mean body weight change at 80 weeks: β¬οΈ New Retatrutide Phase 3 Trial
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 12 - Oct 17










:max_bytes(150000):strip_icc():focal(736x413:738x415)/GLP-1-medication-man-061526-3b50a75cd99749779900fab4c30352e7.jpg)














